- Startpage |
- Lab Products & ServicesLab Products & Services
- Bioprocess SolutionsBioprocess Solutions
As a consequence of the stock split and the increase of the individual par value of the company's shares, Stedim Biotech S.A.’s issued capital amounted to €18.4 million as of December 31, 2016, and was divided into 92,180,190 shares, each with a calculated par value of €0.20. As some of the shares convey double voting rights, there were a total of 162,041,944 voting rights as of the reporting date.
As of December 31, 2016, Sartorius AG holds 74.3% of the share capital and 84.5% of the outstanding voting rights. The remaining 25.7% of the shares are in free float; corresponding to 15.5% of the outstanding voting rights.